Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis

57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015).

Detalhes bibliográficos
Autor principal: Manica, Santiago Rodrigues (author)
Outros Autores: Sepriano, Alexandre (author), Pimentel-Santos, Fernando (author), Gouveia, Nélia (author), Barcelos, Anabela (author), Branco, Jaime C. (author), Bernardes, Miguel (author), Ferreira, Raquel Miriam (author), Vieira-Sousa, Elsa (author), Barreira, Sofia (author), Vinagre, Filipe (author), Roque, Raquel (author), Santos, Helena (author), Madeira, Nathalie (author), Rovisco, João (author), Daniel, Alexandra (author), Ramiro, Sofia (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Ankylosing spondylitis
AS
axSpA
bDMARD
nr-axSpA
r-axSpA
Spondyloarthritis
Switch
TNFi
Treatment
Rheumatology
Immunology and Allergy
Immunology
Texto completo:http://hdl.handle.net/10362/103791
País:Portugal
Oai:oai:run.unl.pt:10362/103791

Texto Completo

http://hdl.handle.net/10362/103791

Registros relacionados